PT Diagnos Laboratorium Utama Tbk

NEW
ISX:DGNS (Indonesia)   Ordinary Shares
Rp 238 +2 (+0.85%) Aug 28
N/A
P/B:
0
Market Cap:
Rp 324.50B ($ 18.33M)
Enterprise V:
Rp 324.50B ($ 18.33M)
Volume:
298.90K
Avg Vol (2M):
472.02K
Warning! GuruFocus detected 1 Severe warning sign with DGNS. Try a 7-Day Free Trial to check it out.
Trade In:
Volume:
298.90K
Market Cap Rp:
324.50B
Market Cap $:
18.33M
N/A
Avg Vol (2M):
472.02K
Enterprise Value Rp:
324.50B
Enterprise Value $:
18.33M
PB Ratio:
0
What is a stock summary page? Click here for an overview. Powered by GuruAPI
Website Sources Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢

PT Diagnos Laboratorium Utama Tbk Stock Historical Dividends and Yields

PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) pays a dividend yield of 0%. The 5-year dividend growth rate is 0%. PT Diagnos Laboratorium Utama Tbk has been paying dividends since 2021.

Below is PT Diagnos Laboratorium Utama Tbk's complete dividend history, ex-dividend dates, payout ratio trends, and dividend yield charts.

Dividend started since

 
2021

Years of Dividend History

 
5
0% (Trailing)
0% (Forward)

Dividend Yield

0
 

Dividend Payout Ratio

0%
 

Growth Rate (5-Year)

0%
 

Yield on Cost (5-Year)

0%
 

3-Year Share Buyback Ratio

* Special dividend is not included in the calculation of dividend per share and related fields

Dividend Growth


PT Diagnos Laboratorium Utama Tbk Dividend History & Ex-Dividend Dates

Complete history of 1 dividend payments by PT Diagnos Laboratorium Utama Tbk since 2021. Each row shows the ex-dividend date, amount per share, record date, pay date, and declaration date.

PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) Dividend History
Ex-Dividend Date Amount Record Date Pay Date Declaration Date
2021-08-06 IDR 4.8 2021-08-09 2021-08-27 2021-08-02

Frequently Asked Questions: ISX:DGNS Dividend

Does PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) pay a dividend?

PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't PT Diagnos Laboratorium Utama Tbk pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks.

What are dividend-paying alternatives to PT Diagnos Laboratorium Utama Tbk?

For dividend-paying alternatives in PT Diagnos Laboratorium Utama Tbk's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.

Also check out

High Yield Dividend Stocks in Gurus' Portfolio
Top dividend stocks of Warren Buffett
Top dividend stocks of George Soros
All-in-one Screener
Screen For High Dividend Stocks

Dividend Yield History

This is the historical trailing annual dividend yield of PT Diagnos Laboratorium Utama Tbk. Buying stocks at higher yield relative its historical values is usually more profitable.

Dividend Per Share History

This the dividend history of PT Diagnos Laboratorium Utama Tbk

Dividend Payout Ratio

This is the historical payout ratio of PT Diagnos Laboratorium Utama Tbk. If the dividend payout ratio is close to or higher than 1, dividends might not be sustainable.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文
Education
Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2026 GuruFocus.com, LLC. All Rights Reserved.